Adis Journals
Browse
- No file added yet -

Certolizumab Pegol for the Treatment of Moderate to Severe Plaque Psoriasis: 16-Week Results from a Phase 2/3 Japanese Study

Download (132.78 kB)
media
posted on 2021-02-17, 10:56 authored by Adis journals on behalf of, Yoshinori Umezawa, Shinya Sakurai, Naoki Hoshii, Hidemi Nakagawa

Article full text


The above summary slide represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).

© The authors, CC-BY-NC 2021.

History

Usage metrics

    Dermatology and Therapy

    Categories

    Keywords

    Certolizumab pegolJapanPlaque psoriasisTumor necrosis factor-alpha

    Licence

    CC BY-NC 4.0

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC